|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 5.220 USD | +3.78% |
|
+4.40% | -40.82% |
| 08-10 | B. Riley Adjusts Vanda Pharmaceuticals Price Target to $12 From $17, Maintains Buy Rating | MT |
| 08-05 | Vanda Pharmaceuticals Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
VNDA 5.220 $
+3.78%
5.04M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| VNDA | 5.220USD | +3.78% | 5.04M $ | |
CBOE
| VNDA | 5.225USD | +4.08% | 185K $ | |
|
Deutsche Boerse AG
| VM4 | 4.246EUR | -3.28% | 0 € | |
|
Börse Stuttgart
| VM4 | 4.466EUR | +3.43% | 0 € | |
|
Tradegate
| VM4 | 4.518EUR | +3.62% | 0 € | |
|
Berne S.E.
| VM4 | 4.054CHF | -2.28% | 0 CHF | |
|
Boerse Muenchen
| VM4 | 4.498EUR | +2.55% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 5.73 | 6.58 | 8.91 |
| Spread/Res. | -8.90% | -20.67% | -41.41% |
| Spread/Supp. | +5.88% | +5.88% | +20.00% |
| Support | 4.93 | 4.93 | 4.35 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
